Drug – bio-affecting and body treating compositions – Enzyme or coenzyme containing – Hydrolases
Patent
1995-01-11
1997-12-09
Jagannathan, Vasu S.
Drug, bio-affecting and body treating compositions
Enzyme or coenzyme containing
Hydrolases
435220, A61K 3848, C12N 952
Patent
active
056957548
ABSTRACT:
A method for producing the derivatives of the invention by preparing a DNA fragment comprising at least the part of the coding sequence of staphylokinase that provides for its biological activity; performing in vitro site-directed mutagenesis on the DNA fragment to replace one or more codons for wild-type amino acids by a codon for another amino acid; cloning the mutated DNA fragment in a suitable vector; transforming or transfecting a suitable host cell with the vector; and culturing the host cell under conditions suitable for expressing the DNA fragment. Preferably the DNA fragment is a 466 bp EcoRI-HINDIII fragment of the plasmid pMEX602SAK, the in vitro site-directed mutagenesis is performed by an oligonucleotide-directed mutagenesis system using the plasmid pMa/c and the repair deficient E. coli strain WK6MutS, and the mutated DNA fragment is cloned in E. coli strain-WK6. The invention also relates to pharmaceutical compositions comprising at least one of the staphylokinase derivatives according to the invention together with a suitable excipient, for treatment of arterial thrombosis.
REFERENCES:
Schlott, et al. Biochimica et Biophysica Acta 1204:235-242 (1994).
Collen Desire
Jagannathan Vasu S.
Lathrop Brian K.
Leuven Research & Development VZW
LandOfFree
Staphylokinase derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Staphylokinase derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Staphylokinase derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1605413